Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
Clinical trial NCT04446793 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04446793
- Sponsor
- Cardiff Oncology
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.